Albumin for cirrhosis-related complications

Area of Science:

• Hepatology
• Clinical Practice Guidelines
• Evidence-Based Medicine

Background:

• Clinical practice guidelines for albumin use in cirrhosis complications have limitations.
• Existing evidence supporting recommendations needs critical evaluation.
• Recent studies may offer updated insights into albumin's role.

Purpose of the Study:

• To discuss limitations in studies underpinning albumin use recommendations for cirrhosis.
• To review recent literature on albumin in cirrhosis-related complications.
• To propose future research directions for albumin application.

Main Methods:

• Literature review of studies on albumin use in cirrhosis.
• Analysis of existing clinical practice guidelines.
• Synthesis of recent research findings.

Main Results:

• No recent comprehensive clinical practice guidelines for albumin exist.
• Specialty association guidelines offer specific recommendations.
• Post-guideline studies aid in defining appropriate albumin indications.

Conclusions:

• Albumin's role in cirrhosis complications requires further investigation.
• High cost and shortages necessitate robust trials.
• Future research should prioritize adequately powered randomized controlled trials evaluating albumin in current care settings.